This is a bridge
bridge people for free
On the road again

Abbott Labs Rolls Out 5-Minute COVID-19 Test—But Are Investors Overly Optimistic?


Abbott Laboratories shares jumped on Monday after the FDA approved its fast COVID-19 test system. Igor Golovniov/SOPA Images/LightRocket via Getty Images

On Friday, Abbott Laboratories received an emergency use approval from the U.S. Food and Drug Administration (FDA) to launch a small, portable COVID-19 test kit that can return results in between five and 13 minutes.

The Chicago-based medical device maker plans to supply 50,000 tests per day across the U.S. starting April 1. “This is really going to provide a tremendous opportunity for front-line caregivers, those having to diagnose a lot of infections, to close the gap with our testing,” John Frels, head of research and development at Abbott Labs’ diagnostics unit, told Bloomberg.[1] “A clinic will be able to turn that result around quickly, while the patient is waiting.”

SEE ALSO: Why Are N95 Face Masks So Expensive and Hard to Find? Mark Cuban Blames 3M[2]

The portable test technology was built on Abbott’s ID Now platform, a widely adopted point-of-care system (weighing only seven pounds) in the U.S. used to detect respiratory diseases including influenza.

In response to Friday’s FDA news, Abbott Labs’ shares jumped over 10 percent Monday morning, making it the hottest stock on Wall Street at the opening of the week. However, market observers caution that, amid the gloomy and highly uncertain market climate right now, investors should curb their optimism when buying in biotech and pharmaceutical stock.[3]

“There is simply too much optimism in the stock market, and in many cases investors are buying without doing research,” Nigam Arora, an investor and founder of The Arora Report, which publishes four financial newsletters, wrote in a column[4] for MarketWatch on Monday.

Taking Abbott Labs as an example of investors’ hasty buying, Arora wrote,”Abbott Labs has come up with a coronavirus test that takes five minutes. The revenues from the coronavirus test will dwarf those that Abbott is likely to lose due to issues related to coronavirus. [So] investors are running up the stock.”

Abbott shares saw its first round of rally last week, after the company’s non-portable of the COVID-19 test system, m2000 RealTime, won the FDA approval to be used in hospitals and labs. m2000 RealTime takes longer than the portable kit to return results, but the system can process up to one million tests a week. Between the two systems, Abbott plans to run at least five million tests a month.

Abbott Labs Rolls Out 5-Minute COVID-19 Test—But Are Investors Overly Optimistic?

Read more

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
DJ Cuppy has revealed that most Nigerians do not like her. In a recent post made by popular DJ Cuppy, she
THE decomposing remains of a supermarket employee who vanished 10 years ago have been discovered in an 18-inch gap behind a freezer...
Cristiano Ronaldo has lost a bid for dismissal or complete secrecy in a federal lawsuit by an American woman who has...
FANS of MICHELLE OBAMA, wife of former US President Barack Obama, are clamouring for her to take a run at the...
Israeli startup targets phone scammers with new biometric trap ‘Hundreds of subtle signs’ are used by BioCatch software to spot a victim of...
The just concluded Islamic pilgrimage or hajj in Saudi Arabia has left 39 pilgrims, including five Filipinos, dead of various causes on...
Heart of a Champion: The Unbelievable Story of Kyle Maynard With no hands or feet, Kyle Maynard could make plenty of excuses. But...
Top 3 Hausa food and how to prepare them Do not miss this chance to taste Top 3 Hausa food and...
RISE ABOVE Zion Shaver left the wrestling mat to a rousing ovation last month. The 88-pound high school senior, born without legs,
Leaders of the five local government areas under Daura Emirate yesterday told President Muhammadu Buhari that they enjoy 24 hours power supply...

google ads


Su servidor no soporta flash players o javascripts, use por favor cualquiera de los siguientes links

google ads